{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:52:48Z","timestamp":1790031168914,"version":"4.0.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0147591","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T19:21:51Z","timestamp":1453749711000},"page":"e0147591","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART"],"prefix":"10.1371","volume":"11","author":[{"given":"Jose Manuel","family":"Vazquez-Guillen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo C.","family":"Palacios-Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia G.","family":"Rivera-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garcia-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Ortiz-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Noguera-Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herlinda J.","family":"Vielma-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa J.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelino","family":"Chavez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Lopez-Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelina","family":"Briones-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz M.","family":"Sanchez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Vazquez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodriguez-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1258\/ijsa.2011.011124","article-title":"Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption","volume":"23","author":"EM Kalmar","year":"2012","journal-title":"Int J STD AIDS"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1128\/JVI.02308-05","article-title":"Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques","volume":"80","author":"KK Van Rompay","year":"2006","journal-title":"J Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/aid.2007.0110","article-title":"Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia","volume":"24","author":"W Borkowsky","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijid.2009.03.003","article-title":"Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off\/12 weeks on therapy in children having chronically undetectable viral load cause progressively smaller viral rebounds","volume":"14","author":"GC Palacios","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e1002527","DOI":"10.1371\/journal.pcbi.1002527","article-title":"Standing genetic variation and the evolution of drug resistance in HIV","volume":"8","author":"PS Pennings","year":"2012","journal-title":"Plos Comput Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/157016211795945250","article-title":"Drug resistance mutations during structured interruptions of HAART in HIV-1 infected children","volume":"9","author":"GC Palacios-Saucedo","year":"2011","journal-title":"Curr HIV Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/jac\/dkr354","article-title":"\u2018Sentinel\u2019 mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing","volume":"66","author":"C Alteri","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e6079","DOI":"10.1371\/journal.pone.0006079","article-title":"Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use","volume":"4","author":"T Le","year":"2009","journal-title":"Plos One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/379215","article-title":"Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions","volume":"188","author":"KJ Metzner","year":"2003","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients","volume":"48","author":"KJ Metzner","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"RR-12","key":"ref11","first-page":"1","article-title":"1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"43","year":"1994","journal-title":"MMWR Recomm Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"SY Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(99)03515-1","article-title":"Structured treatment interruptions to control HIV-1 infection","volume":"355","author":"F Lori","year":"2000","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM200102153440702","article-title":"Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia","volume":"344","author":"SG Deeks","year":"2001","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.2007-1086","article-title":"Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection","volume":"121","author":"A Saitoh","year":"2008","journal-title":"Pediatrics"},{"key":"ref16","first-page":"2401","article-title":"Treatment interruption for virological failure or as sparing regimen in children with chronic HIV-1 infection","volume":"18","author":"F Monpoux","year":"2004","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1001005","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA Viruses","volume":"6","author":"AS Lauring","year":"2010","journal-title":"Plos Pathog"},{"key":"ref18","first-page":"464","article-title":"Monitoring resistance to Human Immunodeficiency Virus type 1 protease inhibitors by pyrosequencing","volume":"39","author":"D O\u2019Meara","year":"2001","journal-title":"J ClinMicrobiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1101\/gr.6468307","article-title":"Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance","volume":"17","author":"C Wang","year":"2007","journal-title":"Genome Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1000074","article-title":"Viral population estimation using pyrosequencing","volume":"4","author":"N Eriksson","year":"2008","journal-title":"Plos Comput Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e9263","DOI":"10.1371\/journal.pone.0009263","article-title":"HIV drug resistance surveillance using pooled pyrosequencing","volume":"5","author":"H Ji","year":"2010","journal-title":"Plos One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e11345","DOI":"10.1371\/journal.pone.0011345","article-title":"Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing","volume":"5","author":"C Hedskog","year":"2010","journal-title":"Plos One"},{"key":"ref23","first-page":"642","article-title":"2014 Update of the Drug Resistance Mutations in HIV-1","volume":"22","author":"AM Wensing","year":"2014","journal-title":"Top Antivir Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.arcmed.2006.05.014","article-title":"Frequency of protease and reverse transcriptase drug resistance mutations in na\u00efve HIV-infected patients","volume":"37","author":"OM Valle-Bahena","year":"2006","journal-title":"Arch Med Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0147591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:05:28Z","timestamp":1589022328000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0147591"}},"subtitle":[],"editor":[{"given":"Paul Richard","family":"Harrigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0147591","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]}}}